Drugmakers warn new law will deter discoveries
David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.
Pharmaceutical
Articles
Next step for obesity drug makers replacing needles with pills
Medical experts predict the pills will be popular, especially among people who want to lose weight but are fearful of needles.
Contract drugmaker Catalent shrinks as pandemic wanes
The New Jersey-based company has announced two large rounds of layoffs at its Bloomington plant within six months—400 workers last December and 150 this month.
Inflation Reduction Act foes race to repeal climate, drug pricing programs
A growing roster of corporate and political foes has started to lay siege to the law, hoping to erode some of its key provisions before they can take effect.
Indiana to receive $19M in opioid settlement funds this year
This year is the second year Indiana has received money from a national settlement with opioid distributors and manufacturers for opioid-related harms.
Insurers clamping down on doctors who prescribe Ozempic for weight loss
Indianapolis-based Elevance Health, which operates Anthem plans, said that in most cases, it won’t cover Ozempic unless a patient is diagnosed with diabetes and has tried another medication to manage it, but physicians can still prescribe it.
Lilly battling rivals for breast-cancer patients
The Indianapolis-based pharmaceutical giant is spending hundreds of millions of dollars to win over patients with an extensive advertising campaign.
Medicare to expand coverage for new class of costly Alzheimer’s drugs
Groups such as the Alzheimer’s Association have pushed Medicare to cover the new Alzheimer’s drugs—including those cleared on an expedited basis—saying that the FDA should be the final arbiter of safety and efficacy of drugs.
Eli Lilly settles class-action insulin lawsuit for $13.5M
Under the agreement, Lilly has agreed to continue its cap on out-of-pocket costs for its users at $35 a month for four years.
SpectronRx teams with Belgian research center to make cancer therapies in Europe
The Indianapolis-based radiopharmaceutical company said it plans to help open a facility in Belgium to make therapeutic agents for cancer patients.
Can new Indiana law lower drug costs? Answer is as clear as mud
Senate Enrolled Act 8 is part of a sweeping effort this year by the Indiana General Assembly to bring down the cost of health care across the state, where prices are among the highest in the country.
Lilly overtakes rival J&J in market cap to become world’s most valuable drugmaker
Eli Lilly and Co. shares have soared 57% over the past 52 weeks, buoyed in part by sales of its diabetes drug Mounjaro, which the company is also preparing to seek approval to market for obesity.
Eli Lilly says experimental drug slows decline from Alzheimer’s
If approved, Donanemab has annual multi-billion-dollar sales potential. Lilly shares rose 6% in early-afternoon trading.
Shortages of prescription drugs growing in United States
There were 301 active national drug shortages through this year’s first quarter, according to the University of Utah Drug Information Service. That’s 49% higher than the 202 recorded in the first three months of 2018.
Powerful new obesity drug poised to upend weight-loss care
If approved for weight loss, Eli Lilly’s tirzepatide could become the most effective drug to date in an arsenal of medications that are transforming the treatment of obesity, which affects more than 4 in 10 American adults and is linked to dozens of diseases.
Purdue lands $100M for cancer drug Pluvicto royalties
Purdue University plans to use the funding to further support research at the university.
Drug manufacturer grows amid contracting boom
Fishers-based INCOG Biopharma Services Inc., one of the newest players in the $132 billion contract drug manufacturing industry, acts as a behind-the-scenes player for companies that need to get sterile injectable medicines to market in a hurry.
Supreme Court temporarily extends access to abortion pill
The court extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s Food and Drug Administration approval continues.
Lilly to invest another $1.6 billion in Boone County site, add 200 jobs
The expansion will bring Eli Lilly and Co.’s total investment in the project to $3.7 billion, the most the company has ever spent on a single manufacturing site.
Indiana legislators OK over-the-counter birth control bill
The Indiana House bill is key to providing women quicker access to contraceptives, bill sponsor Republican Sen. Sue Glick said Tuesday, especially in areas where they struggle to receive primary care.